Induction therapy with adalimumab on top of an aggressive treat-to-target strategy with methotrexate and intraarticular corticosteroid reduces radiographic erosive progression in early rheumatoid arthritis, even after withdrawal of adalimumab. Results of a 2-year trial (OPERA)

Kim Hørslev-Petersen, Lykke Midtbøll Ørnbjerg, Merete Lund Hetland, P. Junker, Jan Pødenphanth, T. Ellingsen, P. Ahlqvist, H.M. Lindegaard, A. Linauskas, A. Schlemmer, M.Y. Dam, I. Hansen, T. Lottenburger, A. Jørgensen, Sophine Boysen Krintel, J. Raun, C.G. Ammitzbøll, Julia Sidenius Johansen, Mikkel Østergaard, K. Steengaard-Pedersen

OriginalsprogEngelsk
TidsskriftArthritis & Rheumatism
Vol/bind65
Udgave nummerSuppl. 10
Sider (fra-til)S600-1
Antal sider2
ISSN0004-3591
StatusUdgivet - 2013

Citationsformater